Illumina is a global company that develops innovative array-based solutions for DNA, RNA, and protein analysis. By empowering the genetic analysis research of the customers, the Company's tools make a difference in disease research, drug development, and the development of molecular tests in the clinic.

Company Growth (employees)
San Diego, US
Size (employees)
5,500 (est)
Illumina was founded in 1998 and is headquartered in San Diego, US

Illumina Office Locations

Illumina has offices in San Diego, Madison, San Francisco, Santa Clara and in 11 other locations
San Diego, US (HQ)
5200 Illumina Way
Victoria, CA
2302 4464 Markham St
Singapore, SG
11 Biopolis Way, #09 05 Helios
Fulbourn, GB
Cpc4, Capital Park
Little Chesterford, GB
Chesterford Research Park Little Chesterford Nr Saffron Walden
Eindhoven, NL
15 Freddy Van Riemsdijkweg
São Paulo, BR
62 787 Alameda Santos
Minato, JP
Mita Bellju Building 22 F Minato Ku, Shiba 5 36 7
Beijing, CN
Rm. 1103 A, Bldg. H, Phoenix Place No. A5 Shuguangxili, Chaoyang District
Shanghai, CN
Rm. 2210, Shui On Plaza, No. 333 Huai Hai Zhong Road
Scoresby, AU
1 International Ct
Redwood City, US
800 Saginaw Dr
Santa Clara, US
210 451 El Camino Real
San Francisco, US
210 499 Illinois St
Madison, US
200 5602 Research Park Blvd

Illumina Data and Metrics

Illumina Financial Metrics

Illumina's revenue was reported to be $2.4 b in FY, 2016 which is a 8% increase from the previous period.

Revenue (FY, 2016)

2.4 b

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

1.7 b

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

428.1 m

EBIT (FY, 2016)

587 m

Market capitalization (27-Jun-2017)

25.8 b

Closing share price (27-Jun-2017)


Cash (31-Dec-2016)

734.5 m
Illumina's current market capitalization is $25.8 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016


1.4 b1.9 b2.2 b2.4 b

Revenue growth, %


Cost of goods sold

670.5 m731.9 m

Gross profit

911.9 m1.3 b1.5 b1.7 b

Gross profit Margin, %


Operating expense total

777.8 m783 m936.4 m1.1 b


134.1 m514.7 m612.8 m587 m

EBIT margin, %


Interest expense

42.1 m33.2 m

Interest income

5 m9.8 m

Pre tax profit

583.1 m561.2 m

Income tax expense

125.8 m133.1 m

Net Income

125.3 m353.4 m457.4 m428.1 m
USDFY, 2013FY, 2014FY, 2015FY, 2016


711.6 m636.2 m768.8 m734.5 m

Accounts Receivable

238.9 m289.5 m385.5 m381.3 m


22.8 m29.8 m54.3 m77.9 m

Current Assets

1.6 b1.9 b2.1 b2.3 b


202.7 m265.3 m342.7 m713.3 m


723.1 m724.9 m752.6 m776 m

Total Assets

3 b3.3 b3.7 b4.3 b

Accounts Payable

73.7 m82.6 m139.2 m137.9 m

Current Liabilities

322.1 m722.2 m610.5 m704.7 m

Additional Paid-in Capital

2.6 b2.2 b2.5 b2.7 b

Retained Earnings

207.9 m561.2 m1 b1.5 b

Total Equity

1.8 b2.3 b

Financial Leverage

2 x1.9 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

125.3 m353.4 m457.4 m428.1 m

Depreciation and Amortization

50.8 m61.9 m72.7 m90 m

Accounts Receivable

(16 m)(50 m)(96 m)3.2 m


1.8 m6.6 m(11 m)(1.2 m)

Accounts Payable

2.4 m(2.1 m)46.3 m(2 m)

Cash From Operating Activities

386.4 m501.3 m659.6 m687.2 m

Purchases of PP&E

(79.2 m)(106 m)(142.8 m)(259.9 m)

Cash From Investing Activities

(69.6 m)(406.6 m)(106.1 m)(514.5 m)

Cash From Financing Activities

(38.7 m)(166.7 m)(418.8 m)(204.7 m)

Income Taxes Paid

50.1 m17.9 m16.9 m59.7 m
USDY, 2016


521.4 k

Financial Leverage

1.9 x

Illumina Market Value History

Illumina Median Salaries

Source: 236 public H-1B filings from Illumina

Illumina Online and Social Media Presence

Illumina News and Updates

Illumina Company Life and Culture

You may also be interested in